Literature DB >> 29389962

Correction: Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.

Ana Carolina Rios Silvino, Gabriel Luiz Costa, Flávia Carolina Faustino de Araújo, David Benjamin Ascher, Douglas Eduardo Valente Pires, Cor Jesus Fernandes Fontes, Luzia Helena Carvalho, Cristiana Ferreira Alves de Brito, Tais Nobrega Sousa.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0160172.].

Entities:  

Year:  2018        PMID: 29389962      PMCID: PMC5794165          DOI: 10.1371/journal.pone.0192534

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There is an error in Table 1. Please see the corrected Table 1 here.
Table 1

Demographic and epidemiological data of individuals who had been enrolled in the study.

CharacteristicsSingle-relapse(n = 28)Multiple-relapse(n = 18)P value
Age, years (mean ± s.d.)33.7 ± 14.735.4 ± 14.60.713a
Previous malaria episode, n (median, IQR)2 (1–6)3 (2–6)0.445b
Parasitemia, parasites/μL (median, IQR)1908 (823–5100)4085 (752–6909)0.377 b
Time to the first relapse, months (median, IQR)1.88 (1.40–2.74)1.71 (1.13–2.10)0.295 b

Abbreviations: s.d., standard deviation; IQR, interquartile range; n, absolute number

aWelch′s t test

bMann-Whitney test

Abbreviations: s.d., standard deviation; IQR, interquartile range; n, absolute number aWelch′s t test bMann-Whitney test
  1 in total

1.  Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.

Authors:  Ana Carolina Rios Silvino; Gabriel Luiz Costa; Flávia Carolina Faustino de Araújo; David Benjamin Ascher; Douglas Eduardo Valente Pires; Cor Jesus Fernandes Fontes; Luzia Helena Carvalho; Cristiana Ferreira Alves de Brito; Tais Nobrega Sousa
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  1 in total
  1 in total

1.  Prediction of the CYP2D6 enzymatic activity based on investigating of the CYP2D6 genotypes around the vivax malaria patients in Yunnan Province, China.

Authors:  Ying Dong; Herong Huang; Yan Deng; Yanchun Xu; Mengni Chen; Yan Liu; Canglin Zhang
Journal:  Malar J       Date:  2021-11-25       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.